Maridose Scientific Advisory Board
DINNER SPEAKER
SCIENCE
Professor Lumir Ondrej Hanus is a world-renowned analytical chemist and a leading figure in the field of cannabis research. Professor Hanus is responsible for groundbreaking research in the world of cannabinoids and his award-winning research serves as the basis for much of what we know about the plant today.
Formerly served as the Chief Scientist of Lumir Lab, Asana Bio Group Ltd., and with The Institute for Drug Research School of Pharmacy, Faculty of Medicine Hebrew University.
Professor Hanus isolated the first known endocannabinoid in the human brain, Anandamide, named after the Sanskrit word for bliss. The discovery of Anandamide confirmed that the human brain produces "cannabinoids" of its own, called endocannabinoids, which bind with cannabinoid receptors throughout the brain and body. Evidence suggests these cannabinoid receptors are involved in neuroprotection, pain modulation, memory processing, motor coordination, control of appetite, and more.
Since Professor Hanus's immense discovery, thousands of studies have been conducted on the endocannabinoid system and cannabinoids of all kinds. The transformative revelation has affected and more importantly shaped the industry as we now know it. Meanwhile, additional cannabinoids from the plant, and endocannabinoids from humans and other living organisms, continue to be discovered.
Lumír Ondřej Hanuš (* November 20, 1947) obtained his M.S. in analytical chemistry (1972), Ph.D. in analytical chemistry (1974), and associate professor in organic chemistry (1994) from Palacký University (Olomouc, Czech Republic) and his D.Sc. in pharmaceutical chemistry (1995) from Charles University (Prague, Czech Republic). Between 1971 and 1990, did research on cannabis and taught hygiene at the Medical Faculty, Palacký University (Olomouc), 1976-1978 Postgraduate studies of Modern instrumental chemistry (Jan Evangelista Purkyně University, Brno). Period 1978–1979 spent as a research associate at the School of Pharmacy, University of Mississippi, USA.
From 1990 up to 2020 (as a researcher, professor, chaver, and research fellow) with the School of Pharmacy (Hebrew University, Jerusalem, Israel). Between the years 1997 and 1998 was a visiting associate (NIDDK, NIH, Bethesda, USA), and in 2001–2002 a research fellow at NIAAA (NIH, Bethesda, USA). Steering Committee member (CMCER) and Senior Fellow at the Jefferson Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania (from 2017 to 2019). Visiting professor, Centro de Estudios Interdisciplinarios, Universidad Nacional de Rosario, Rosario, Argentina, 2021. At present time, he is Chief Scientist at Lumir Lab (Asana Bio Group Ltd.) and retired Professor Chaver and Research Fellow of Hebrew University in Jerusalem.
He was awarded Honorary Doctorate degree - Chemiae Doctor honoris causa (2007) and Medicinae Doctor honoris causa (2011), Hanuš medal (2005), Memorial medal (2006), Outstanding Immigrant Scientist in Life Sciences and Medicine (2010), Addictology Award (2012), Recognition (Ljubljana 2014), Olomouc City Award (2013), Lifetime Award Winner (Washington D.C., 2016), Commemorative Medal of the Palacký University in Olomouc for extraordinary representation of Palacký University in the Czech Republic and abroad (2016) and Lifetime Achievement Award (Jamaica, 2018).
On March 24, 1992, he was the first person to isolate from the brain the first endogenous ligand for cannabinoid receptors which was named anandamide. The discovery of this first endocannabinoid opened the world to the medicinal use of cannabis.
ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.
